Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Arthritis and Rheumatism
|
June 11, 1992
Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis
T V Kantor, T L Whiteside, D Friberg, et al.
Clinical Immunology and Immunopathology
|
December 11, 1992
Cytokine production and serum levels in systemic sclerosis
T V Kantor, D Friberg, T A Medsger, et al.
The Journal of Rheumatology
|
September 1, 1980
Bleomycin-induced scleroderma
W R Finch, G P Rodnan, R B Buckingham, et al.
Arthritis and Rheumatism
|
February 1, 1985
Soluble mediators from mononuclear cells increase the synthesis of glycosaminoglycan by dermal fibroblast cultures derived from normal subjects and progressive systemic sclerosis patients
T L Whiteside, J G Worrall, R K Prince, et al.
Arthritis and Rheumatism
|
February 1, 1980
Collagen types synthesized in dermal fibroblast cultures from patients with early progressive systemic sclerosis
R E Gay, R B Buckingham, R K Prince, et al.
Arthritis and Rheumatism
|
January 1, 1986
Persistence of scleroderma-like phenotype in normal fibroblasts after prolonged exposure to soluble mediators from mononuclear cells
J G Worrall, T L Whiteside, R K Prince, et al.
Arthritis and Rheumatism
|
October 1, 1988
Systemic joint laxity (the hypermobile joint syndrome) is associated with temporomandibular joint dysfunction
D Harinstein, R B Buckingham, T Braun, et al.
Arthritis and Rheumatism
|
April 1, 1983
Clinical and serologic study of Sjögren's syndrome in patients with progressive systemic sclerosis
T A Osial, T L Whiteside, R B Buckingham, et al.
Oral Surgery, Oral Medicine, and Oral Pathology
|
November 1, 1991
Temporomandibular joint dysfunction syndrome: a close association with systemic joint laxity (the hypermobile joint syndrome)
R B Buckingham, T Braun, D A Harinstein, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1977
Effects of halofenate and probenecid on serum lipids and uric acid in hyperlipidemic, hyperuricemic adults
D R Bassett, W M Mikkelsen, R B Buckingham, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Arthritis and Rheumatism
|
June 11, 1992
Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis
T V Kantor, T L Whiteside, D Friberg, et al.
Clinical Immunology and Immunopathology
|
December 11, 1992
Cytokine production and serum levels in systemic sclerosis
T V Kantor, D Friberg, T A Medsger, et al.
The Journal of Rheumatology
|
September 1, 1980
Bleomycin-induced scleroderma
W R Finch, G P Rodnan, R B Buckingham, et al.
Arthritis and Rheumatism
|
February 1, 1985
Soluble mediators from mononuclear cells increase the synthesis of glycosaminoglycan by dermal fibroblast cultures derived from normal subjects and progressive systemic sclerosis patients
T L Whiteside, J G Worrall, R K Prince, et al.
Arthritis and Rheumatism
|
February 1, 1980
Collagen types synthesized in dermal fibroblast cultures from patients with early progressive systemic sclerosis
R E Gay, R B Buckingham, R K Prince, et al.
Arthritis and Rheumatism
|
January 1, 1986
Persistence of scleroderma-like phenotype in normal fibroblasts after prolonged exposure to soluble mediators from mononuclear cells
J G Worrall, T L Whiteside, R K Prince, et al.
Arthritis and Rheumatism
|
October 1, 1988
Systemic joint laxity (the hypermobile joint syndrome) is associated with temporomandibular joint dysfunction
D Harinstein, R B Buckingham, T Braun, et al.
Arthritis and Rheumatism
|
April 1, 1983
Clinical and serologic study of Sjögren's syndrome in patients with progressive systemic sclerosis
T A Osial, T L Whiteside, R B Buckingham, et al.
Oral Surgery, Oral Medicine, and Oral Pathology
|
November 1, 1991
Temporomandibular joint dysfunction syndrome: a close association with systemic joint laxity (the hypermobile joint syndrome)
R B Buckingham, T Braun, D A Harinstein, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1977
Effects of halofenate and probenecid on serum lipids and uric acid in hyperlipidemic, hyperuricemic adults
D R Bassett, W M Mikkelsen, R B Buckingham, et al.
Page
of 4